A dosimetric study on radiation‑induced hypothyroidism following intensity‑modulated radiotherapy in patients with nasopharyngeal carcinoma

Xu,Yumei; Shao,Zhiying; Tang,Tianyou; Liu,Guihong; Yao,Yuanhu; Wang,Jianshe; Zhang,Longzhen

doi:10.3892/ol.2018.9332

A dosimetric study on radiation‑induced hypothyroidism following intensity‑modulated radiotherapy in patients with nasopharyngeal carcinoma

Authors:
- Yumei Xu
- Zhiying Shao
- Tianyou Tang
- Guihong Liu
- Yuanhu Yao
- Jianshe Wang
- Longzhen Zhang
View Affiliations

Affiliations: Department of Radiation Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221006, P.R. China, Department of Oncology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221006, P.R. China
Published online on: August 20, 2018 https://doi.org/10.3892/ol.2018.9332
Pages: 6126-6132

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The objective of the present study was to investigate the association between thyroid gland‑dosimetric parameters and hypothyroidism induced by intensity‑modulated radiotherapy in patients with nasopharyngeal carcinoma (NPC). A total of 52 patients with NPC treated in the Department of Radiation Oncology of The Affiliated Hospital of Xuzhou Medical University, from May 2008 to December 2016 were retrospectively enrolled in the present study and divided into two groups based on thyroid function: The euthyroid and hypothyroid groups. The association between hypothyroidism and clinical or dosimetric parameters were analyzed. Females had a significantly increased probability of suffering from radiation‑induced hypothyroidism (RIHT), compared with males (P=0.010). The occurrence of RIHT was significantly negatively associated with thyroid volume prior to radiotherapy (P=0.048). Furthermore, the mean dose (Dmean) and V50 in the hypothyroidism group were significantly increased, compared with the euthyroidism group (P=0.017 and P=0.023, respectively). During the treatment optimization period, dose constraints associated with the thyroid gland demonstrated a significantly protective effect on thyroid function compared with the unconstrained group (P=0.034). According to the receiver operating characteristic curves, the threshold value was 5,160 cGy for Dmean and 54.5% for V50. The 3‑year cumulative incidence of RIHT was 67.8% when the Dmean value was >5,160 cGy and 44.6% when the Dmean was <5,160 cGy (log rank test, P=0.036). Furthermore, the 3‑year cumulative incidence was 66.1% when the V50 was >54.5%, and 29.9% when the V50 was <54.5% (log rank test, P=0.025). In conclusion, RIHT is associated with radiation dose, particularly with Dmean and V50 of the thyroid gland. Dose constraints associated with the thyroid gland significantly reduced the incidence of hypothyroidism compared with the unconstrained group.

View Figures

View References

1	Yi HM, Yi H, Zhu JF, Xiao T, Lu SS, Guan YJ and Xiao ZQ: A five-variable signature predicts radioresistance and prognosis in nasopharyngeal carcinoma patients receiving radical radiotherapy. Tumour Biol. 37:2941–2949. 2016. View Article : Google Scholar : PubMed/NCBI
2	Boomsma MJ, Bijl HP and Langendijk JA: Radiation-induced hypothyroidism in head and neck cancer patients: A systematic review. Radiother Oncol. 99:1–5. 2011. View Article : Google Scholar : PubMed/NCBI
3	Vanderpump MP and Tunbridge WM: Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid. 12:839–847. 2002. View Article : Google Scholar : PubMed/NCBI
4	Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL and Trotti A: AJCC cancer staging manual. 7th. Springer-Verlag; New York, NY: 2010
5	Tian YM, Xiao WW, Bai L, Liu XW, Zhao C, Lu TX and Han F: Impact of primary tumor volume and location on the prognosis of patients with locally recurrent nasopharyngeal carcinoma. Chin J Cancer. 34:247–253. 2015. View Article : Google Scholar : PubMed/NCBI
6	Duntas LH and Brenta G: The effect of thyroid disorders on lipid levels and metabolism. Med Clin North Am. 96:269–281. 2012. View Article : Google Scholar : PubMed/NCBI
7	Laulund AS, Nybo M, Brix TH, Abrahamsen B, Jørgensen HL and Hegedüs L: Duration of thyroid dysfunction correlates with all-cause mortality. The OPENTHYRO register cohort. PLoS One. 9:e1104372014. View Article : Google Scholar : PubMed/NCBI
8	Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, et al: AJCC Cancer Staging Manual. Eigth edition. Springer-Verlag; New York, NY: 2017, View Article : Google Scholar
9	Zohar Y, Tovim RB, Laurian N and Laurian L: Thyroid function following radiation and surgical therapy in head and neck malignancy. Head Neck Surg. 6:948–952. 1984. View Article : Google Scholar : PubMed/NCBI
10	Hancock SL, Cox RS and McDougall IR: Thyroid disease after treatment of Hodgkin'S disease. N Engl J Med. 325:599–605. 1991. View Article : Google Scholar : PubMed/NCBI
11	Peng YL, Chen L, Shen GZ, Li YN, Yao JJ, Xiao WW, Yang L, Zhou S, Li JX, Cheng WQ, et al: Interobserver variations in the delineation of target volumes and organs at risk and their impact on dose distribution in intensity-modulated radiation therapy for nasopharyngeal carcinoma. Oral Oncol. 82:1–7. 2018. View Article : Google Scholar : PubMed/NCBI
12	Mercado G, Adelstein DJ, Saxton JP, Secic M, Larto MA and Lavertu P: Hypothyroidism: A frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer. 92:2892–2897. 2001. View Article : Google Scholar : PubMed/NCBI
13	Tell R, Lundell G, Nilsson B, Sjödin H, Lewin F and Lewensohn R: Long-term incidence of hypothyroidism after radiotherapy in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 60:395–400. 2004. View Article : Google Scholar : PubMed/NCBI
14	Cella L, Liuzzi R, Conson M, D'Avino V, Salvatore M and Pacelli R: Development of multivariate NTCP models for radiation-induced hypothyroidism: A comparative analysis. Radiat Oncol. 7:2242012. View Article : Google Scholar : PubMed/NCBI
15	Feen Rønjom M: Radiation-induced hypothyroidism after treatment of head and neck cancer. Dan Med J. 63:2016.
16	Lin Z, Wu VW, Lin J, Feng H and Chen L: A longitudinal study on the radiation-induced thyroid gland changes after external beam radiotherapy of nasopharyngeal carcinoma. Thyroid. 21:19–23. 2011. View Article : Google Scholar : PubMed/NCBI
17	Tell R, Sjödin H, Lundell G, Lewin F and Lewensohn R: Hypothyroidism after external radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 39:303–308. 1997. View Article : Google Scholar : PubMed/NCBI
18	Diaz R, Jaboin JJ, Morales-Paliza M, Koehler E, Phillips JG, Stinson S, Gilbert J, Chung CH, Murphy BA, Yarbrough WG, et al: Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 77:468–476. 2010. View Article : Google Scholar : PubMed/NCBI
19	Colevas AD, Read R, Thornhill J, Adak S, Tishler R, Busse P, Li Y and Posner M: Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 51:599–604. 2001. View Article : Google Scholar : PubMed/NCBI
20	Wu YH, Wang HM, Chen HH, Lin CY, Chen EY, Fan KH, Huang SF, Chen IH, Liao CT, Cheng AJ and Chang JT: Hypothyroidism after radiotherapy for nasopharyngeal cancer patients. Int J Radiat Oncol Biol Phys. 76:1133–1139. 2010. View Article : Google Scholar : PubMed/NCBI
21	Murthy V, Narang K, Ghosh-Laskar S, Gupta T, Budrukkar A and Agrawal JP: Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: Prospective data from 2 randomized controlled trials. Head Neck. 36:1573–1580. 2014. View Article : Google Scholar : PubMed/NCBI
22	August M, Wang J, Plante D and Wang CC: Complications associated with therapeutic neck radiation. J Oral Maxillofac Surg. 54:1409–1416. 1996. View Article : Google Scholar : PubMed/NCBI
23	Grande C: Hypothyroidism following radiotherapy for head and neck cancer: Multivariate analysis of risk factors. Radiother Oncol. 25:31–36. 1992. View Article : Google Scholar : PubMed/NCBI
24	Cella L, Conson M, Caterino M, De Rosa N, Liuzzi R, Picardi M, Grimaldi F, Solla R, Farella A, Salvatore M and Pacelli R: Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys. 82:1802–1808. 2012. View Article : Google Scholar : PubMed/NCBI
25	Kim MY, Yu T and Wu HG: Dose-volumetric parameters for predicting hypothyroidism after radiotherapy for head and neck cancer. Jpn J Clin Oncol. 44:331–337. 2014. View Article : Google Scholar : PubMed/NCBI
26	Sachdev S, Refaat T, Bacchus ID, Sathiaseelan V and Mittal BB: Thyroid V50 highly predictive of hypothyroidism in head-and-neck cancer patients treated with intensity-modulated radiotherapy (IMRT). Am J Clin Oncol. 40:413–417. 2017. View Article : Google Scholar : PubMed/NCBI
27	Boomsma MJ, Bijl HP, Christianen ME, Beetz I, Chouvalova O, Steenbakkers RJ, van der Laan BF, Wolffenbuttel BH, Oosting SF, Schilstra C and Langendijk JA: A prospective cohort study on radiation-induced hypothyroidism: Development of an NTCP model. Int J Radiat Oncol Biol Phys. 84:e351–e363. 2012. View Article : Google Scholar : PubMed/NCBI
28	Akgun Z, Atasoy BM, Ozen Z, Yavuz D, Gulluoglu B, Sengoz M and Abacioglu U: V30 as a predictor for radiation-induced hypothyroidism: A dosimetric analysis in patients who received radiotherapy to the neck. Radiat Oncol. 9:1042014. View Article : Google Scholar : PubMed/NCBI
29	Fujiwara M, Kamikonya N, Odawara S, Suzuki H, Niwa Y, Takada Y, Doi H, Terada T, Uwa N, Sagawa K and Hirota S: The threshold of hypothyroidism after radiation therapy for head and neck cancer: A retrospective analysis of 116 cases. J Radiat Res. 56:577–582. 2015. View Article : Google Scholar : PubMed/NCBI
30	Huang S, Wang X, Hu C and Ying H: Hypothalamic-pituitary-thyroid dysfunction induced by intensity-modulated radiotherapy (IMRT) for adult patients with nasopharyngeal carcinoma. Med Oncol. 30:7102013. View Article : Google Scholar : PubMed/NCBI